198 related articles for article (PubMed ID: 29784949)
1. Neuronal activity regulates DROSHA via autophagy in spinal muscular atrophy.
Gonçalves IDCG; Brecht J; Thelen MP; Rehorst WA; Peters M; Lee HJ; Motameny S; Torres-Benito L; Ebrahimi-Fakhari D; Kononenko NL; Altmüller J; Vilchez D; Sahin M; Wirth B; Kye MJ
Sci Rep; 2018 May; 8(1):7907. PubMed ID: 29784949
[TBL] [Abstract][Full Text] [Related]
2. Spinal muscular atrophy and the antiapoptotic role of survival of motor neuron (SMN) protein.
Anderton RS; Meloni BP; Mastaglia FL; Boulos S
Mol Neurobiol; 2013 Apr; 47(2):821-32. PubMed ID: 23315303
[TBL] [Abstract][Full Text] [Related]
3. Blocking p62-dependent SMN degradation ameliorates spinal muscular atrophy disease phenotypes.
Rodriguez-Muela N; Parkhitko A; Grass T; Gibbs RM; Norabuena EM; Perrimon N; Singh R; Rubin LL
J Clin Invest; 2018 Jul; 128(7):3008-3023. PubMed ID: 29672276
[TBL] [Abstract][Full Text] [Related]
4. Cell-type-specific miR-431 dysregulation in a motor neuron model of spinal muscular atrophy.
Wertz MH; Winden K; Neveu P; Ng SY; Ercan E; Sahin M
Hum Mol Genet; 2016 Jun; 25(11):2168-2181. PubMed ID: 27005422
[TBL] [Abstract][Full Text] [Related]
5. Established Stem Cell Model of Spinal Muscular Atrophy Is Applicable in the Evaluation of the Efficacy of Thyrotropin-Releasing Hormone Analog.
Ohuchi K; Funato M; Kato Z; Seki J; Kawase C; Tamai Y; Ono Y; Nagahara Y; Noda Y; Kameyama T; Ando S; Tsuruma K; Shimazawa M; Hara H; Kaneko H
Stem Cells Transl Med; 2016 Feb; 5(2):152-63. PubMed ID: 26683872
[TBL] [Abstract][Full Text] [Related]
6. Stasimon Contributes to the Loss of Sensory Synapses and Motor Neuron Death in a Mouse Model of Spinal Muscular Atrophy.
Simon CM; Van Alstyne M; Lotti F; Bianchetti E; Tisdale S; Watterson DM; Mentis GZ; Pellizzoni L
Cell Rep; 2019 Dec; 29(12):3885-3901.e5. PubMed ID: 31851921
[TBL] [Abstract][Full Text] [Related]
7. Tissue-specific models of spinal muscular atrophy confirm a critical role of SMN in motor neurons from embryonic to adult stages.
Laird AS; Mackovski N; Rinkwitz S; Becker TS; Giacomotto J
Hum Mol Genet; 2016 May; 25(9):1728-38. PubMed ID: 26908606
[TBL] [Abstract][Full Text] [Related]
8. A Perturbed MicroRNA Expression Pattern Characterizes Embryonic Neural Stem Cells Derived from a Severe Mouse Model of Spinal Muscular Atrophy (SMA).
Luchetti A; Ciafrè SA; Murdocca M; Malgieri A; Masotti A; Sanchez M; Farace MG; Novelli G; Sangiuolo F
Int J Mol Sci; 2015 Aug; 16(8):18312-27. PubMed ID: 26258776
[TBL] [Abstract][Full Text] [Related]
9. Modeling the differential phenotypes of spinal muscular atrophy with high-yield generation of motor neurons from human induced pluripotent stem cells.
Lin X; Li JJ; Qian WJ; Zhang QJ; Wang ZF; Lu YQ; Dong EL; He J; Wang N; Ma LX; Chen WJ
Oncotarget; 2017 Jun; 8(26):42030-42042. PubMed ID: 28159932
[TBL] [Abstract][Full Text] [Related]
10. miRNA malfunction causes spinal motor neuron disease.
Haramati S; Chapnik E; Sztainberg Y; Eilam R; Zwang R; Gershoni N; McGlinn E; Heiser PW; Wills AM; Wirguin I; Rubin LL; Misawa H; Tabin CJ; Brown R; Chen A; Hornstein E
Proc Natl Acad Sci U S A; 2010 Jul; 107(29):13111-6. PubMed ID: 20616011
[TBL] [Abstract][Full Text] [Related]
11. Astrocyte-produced miR-146a as a mediator of motor neuron loss in spinal muscular atrophy.
Sison SL; Patitucci TN; Seminary ER; Villalon E; Lorson CL; Ebert AD
Hum Mol Genet; 2017 Sep; 26(17):3409-3420. PubMed ID: 28637335
[TBL] [Abstract][Full Text] [Related]
12. miRNA in spinal muscular atrophy pathogenesis and therapy.
Magri F; Vanoli F; Corti S
J Cell Mol Med; 2018 Feb; 22(2):755-767. PubMed ID: 29160009
[TBL] [Abstract][Full Text] [Related]
13. SMN deficiency negatively impacts red pulp macrophages and spleen development in mouse models of spinal muscular atrophy.
Khairallah MT; Astroski J; Custer SK; Androphy EJ; Franklin CL; Lorson CL
Hum Mol Genet; 2017 Mar; 26(5):932-941. PubMed ID: 28062667
[TBL] [Abstract][Full Text] [Related]
14. The potential role of miRNA therapies in spinal muscle atrophy.
Gandhi G; Abdullah S; Foead AI; Yeo WWY
J Neurol Sci; 2021 Aug; 427():117485. PubMed ID: 34015517
[TBL] [Abstract][Full Text] [Related]
15. Expression of Muscle-Specific MiRNA 206 in the Progression of Disease in a Murine SMA Model.
Valsecchi V; Boido M; De Amicis E; Piras A; Vercelli A
PLoS One; 2015; 10(6):e0128560. PubMed ID: 26030275
[TBL] [Abstract][Full Text] [Related]
16. Hypothermia improves disease manifestations in SMA mice via SMN augmentation.
Tsai LK; Chen CL; Tsai YC; Ting CH; Chien YH; Lee NC; Hwu WL
Hum Mol Genet; 2016 Feb; 25(4):631-41. PubMed ID: 26647309
[TBL] [Abstract][Full Text] [Related]
17. Chronic treatment with lithium does not improve neuromuscular phenotype in a mouse model of severe spinal muscular atrophy.
Dachs E; Piedrafita L; Hereu M; Esquerda JE; Calderó J
Neuroscience; 2013 Oct; 250():417-33. PubMed ID: 23876328
[TBL] [Abstract][Full Text] [Related]
18. Normalization of Patient-Identified Plasma Biomarkers in SMNΔ7 Mice following Postnatal SMN Restoration.
Arnold WD; Duque S; Iyer CC; Zaworski P; McGovern VL; Taylor SJ; von Herrmann KM; Kobayashi DT; Chen KS; Kolb SJ; Paushkin SV; Burghes AH
PLoS One; 2016; 11(12):e0167077. PubMed ID: 27907033
[TBL] [Abstract][Full Text] [Related]
19. Decreased stathmin expression ameliorates neuromuscular defects but fails to prolong survival in a mouse model of spinal muscular atrophy.
Wen HL; Ting CH; Liu HC; Li H; Lin-Chao S
Neurobiol Dis; 2013 Apr; 52():94-103. PubMed ID: 23268200
[TBL] [Abstract][Full Text] [Related]
20. SMA Human iPSC-Derived Motor Neurons Show Perturbed Differentiation and Reduced miR-335-5p Expression.
Murdocca M; Ciafrè SA; Spitalieri P; Talarico RV; Sanchez M; Novelli G; Sangiuolo F
Int J Mol Sci; 2016 Jul; 17(8):. PubMed ID: 27483257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
